OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
Key Takeaways
- •The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
- •This story was reported by TechCrunch AI, covering developments in the news space.
- •AI advancements continue to reshape industries — read the full article on TechCrunch AI for complete coverage.
📖 Continue reading the full article:
Read Full Article on TechCrunch AI →


